HAP Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-27,698
Closed -$1.26M 1179
2018
Q1
$1.34M Buy
27,698
+2,593
+10% +$145K 0.07% 190
2017
Q4
$988K Buy
+25,105
New +$938K 0.04% 279

Other funds holding GBT

HAP Trading's GBT Position: Q2 2018 in Review

HAP Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2018, closing a stake of 27,698 shares — an estimated $1.26M sold.

HAP Trading first reported a position in GBT in Q4 2017 and held it in 2 quarters. The position peaked at $1.34M in Q1 2018. 196 funds tracked by Wall St. Rank hold GBT as of Q2 2018.

  • HAP Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • HAP Trading sold 27,698 Global Blood Therapeutics, Inc. shares in Q2 2018, an estimated $1.26M.
  • HAP Trading first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
  • HAP Trading's Global Blood Therapeutics, Inc. position peaked at $1.34M in Q1 2018.
  • 196 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2018.

Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.